Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
19m agoStandard Motor Products, Inc. Announces First Quarter 2026 Earnings Conference Call
53m agoRoundtable Founders, Tech Platform Visionaries unite, to launch the Impossible. AI Powered, DeFi Media Platform at the “Possible” 2026 Media Conference
1h agoPacific Valley Bancorp Shows Continued Growth in Loans and Deposits and Improved Profitability in the First Quarter of 2026
1h agoU-BX Technology Ltd. Announces Pricing of $4.55 Million Registered Direct Offering
1h agoCompany’s 3-for-1 Stock Split Cleared by FINRA for OTC Markets Trading
Day One Biopharmaceuticals Inc logo

Day One Biopharmaceuticals Inc

About

Day One Biopharmaceuticals Inc (NASDAQ:DAWN) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 6 2026
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Feb 24 2026
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
Feb 10 2026
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
Jan 11 2026
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
Jan 6 2026
Day One Completes Acquisition of Mersana Therapeutics

Financials

Revenue
$158.18 M
Market Cap
$2.22 B
EPS
-1.04

Community Chat

Ask AI

6ix6ix